News
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
Ananda Lewis should still be alive. She had access. She had options. What she didn’t have was trust in the system that could ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Efforts to eliminate pass-fail grading in medical schools are misguided attempts to undermine the value of a diverse ...
Guidance from the Office of the General Counsel at the Department of Health and Human Services, obtained by STAT, outlines a ...
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
We cannot and will not gamble with our patients’ health or the health of our communities,” write the presidents of the AAFP, ...
Forget tariffs. Another tool of economic statecraft is far better suited to the problem of illegally manufactured fentanyl.
WASHINGTON — President Trump on Friday signed his landmark tax bill, setting in motion transformational health care ...
The Vaccine Integrity Project will convene experts to assess the evidence on influenza, RSV, and Covid-19 to equip clinicians ...
Defenders of Medicaid cuts point to the Oregon Health Insurance Experiment to argue that the cuts won’t harm people’s health.
Cutting Medicaid will affect all children through a large toll on pediatric health systems,” writes a pediatric ICU physician ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results